Howard Thomas J, Temple Michael B
Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA.
J Am Coll Surg. 2002 Dec;195(6):759-67. doi: 10.1016/s1072-7515(02)01494-1.
Use of appropriate prophylactic antibiotics has been shown to decrease infectious complications and mortality rate in patients with severe acute pancreatitis, but its influence on the bacteriology of secondary pancreatic infection is poorly defined.
Operative cultures from 61 consecutive patients with pancreatic necrosis treated during routine prophylactic antibiotic use (1993-2001) were compared with 34 consecutive patients with necrosis treated before routine antibiotic use (1977-1992).
The two groups of patients were similar in demographics, etiology of pancreatitis, and severity of illness. All patients in the antibiotic group received prophylactic antibiotics compared with only 38% (13 of 34) in the control group. Routine broad-spectrum prophylactic antibiotics altered the bacteriology of secondary pancreatic infection in severe acute pancreatitis from predominantly gram-negative coliforms (56% versus 26%, p = 0.005) to predominately gram-positive organisms (23% versus 52%, p = 0.009) without a significant increase in either the rate of beta-lactam resistance or fungal infections. The overall hospital stay in patients treated with prophylactic antibiotics was significantly reduced (61 +/- 24 days versus 41 +/- 28 days, p = 0.002), and there was a trend toward a decline in mortality rate in the antibiotic treatment group.
Routine broad-spectrum prophylactic antibiotic use has altered the bacteriology of secondary pancreatic infection in severe acute pancreatitis from predominantly gram-negative coliforms to predominantly gram-positive organisms without altering the rate of beta-lactam resistance or fungal superinfection.
已证明使用适当的预防性抗生素可降低重症急性胰腺炎患者的感染性并发症和死亡率,但其对继发性胰腺感染细菌学的影响尚不明确。
将1993年至2001年常规预防性抗生素使用期间连续治疗的61例胰腺坏死患者的手术培养结果与1977年至1992年常规抗生素使用前连续治疗的34例坏死患者的结果进行比较。
两组患者在人口统计学、胰腺炎病因和疾病严重程度方面相似。抗生素组的所有患者均接受了预防性抗生素治疗,而对照组仅38%(34例中的13例)接受了治疗。常规广谱预防性抗生素改变了重症急性胰腺炎继发性胰腺感染的细菌学,从主要为革兰氏阴性大肠菌(56%对26%,p = 0.005)变为主要为革兰氏阳性菌(23%对52%,p = 0.009),且β-内酰胺耐药率或真菌感染率均未显著增加。接受预防性抗生素治疗的患者的总体住院时间显著缩短(61±24天对41±28天,p = 0.002),抗生素治疗组的死亡率有下降趋势。
常规使用广谱预防性抗生素改变了重症急性胰腺炎继发性胰腺感染的细菌学,从主要为革兰氏阴性大肠菌变为主要为革兰氏阳性菌,且未改变β-内酰胺耐药率或真菌二重感染率。